Sodium-Glucose Linked Transporter 2 (SGLT2) Inhibitors—Fighting Diabetes from a New Perspective Theodoros P. AngelopoulosJohn Doupis Review 28 June 2014 Pages: 579 - 591
24-Hour Efficacy of Travoprost/Timolol BAK-Free Versus Latanoprost/Timolol Fixed Combinations in Patients Insufficiently Controlled with Latanoprost Anastasios G. P. KonstasIrini C. VoudouragkakiMalik Y. Kahook Original Research 12 June 2014 Pages: 592 - 603
Safety and Tolerability of Tapentadol Extended Release in Moderate to Severe Chronic Osteoarthritis or Low Back Pain Management: Pooled Analysis of Randomized Controlled Trials Mila EtropolskiBrigitte KuperwasserFrank Laschewski Original Research 02 July 2014 Pages: 604 - 620
Empagliflozin Monotherapy in Japanese Patients with Type 2 Diabetes Mellitus: a Randomized, 12-Week, Double-Blind, Placebo-Controlled, Phase II Trial Takashi KadowakiMasakazu HanedaUli C. Broedl Original Research 24 June 2014 Pages: 621 - 638
The Clinical Impact of Different Coagulometers on Patient Outcomes Jan Leendert Pouwel BrouwerHugo StoevelaarChristoph Sucker Original Research Open access 04 June 2014 Pages: 639 - 656